To see only press releases which have been disclosed pursuant to legislation or other regulations, please select “Regulatory releases” below.
Stock Exchange Releases
English
MAC Clinical Research converts its receivable into shares in Initiator Pharma
The Board of Directors of Initiator Pharma A/S, company reg. (CVR) no. 37663808, (“Initiator” or the “Company”) has today resolved to carry out a capital increase directed at MAC Clinical Research Finance Ltd (“MAC”) in connection with MAC’s conversion notice regarding conversion of outstanding receivable on February 20th.
Issuance of new shares and directed share buyback, as well as the sale of shares in connection with the long-term incentive program for 2021
The Board of Directors of Initiator Pharma A/S, company reg. (CVR) no. 37663808, (“Initiator” or the “Company”) has today resolved to carry out a capital increase directed at members of executive management and key management under the long term incentive program for 2021 (“LTI2021-program”) and to conduct a directed buyback of shares in order to sell shares to the board of directors under the LTI2021-program.